Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced the launch of an inaugural awareness day for anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer …
In a research report released on Monday, H.C.
In a research report sent to investors, Cowen analyst Phil Nadeau maintained a Market Perform rating on Ariad Pharmaceuticals (NASDAQ:ARIA) with a $4.50 …
J.P.
In a research report issued this morning, H.C.
In a research report published today, H.C.
In a research note issued today, H.C.